Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

ACOART BTK RENEW：A Post Market Clinical Study

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos\&Tulip Drug-coated Balloon catheters in the treatment of lesions in below-the-knee artery.

Participants needed: 107
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Acotec Scientific Co., LtdUpdated: Aug 1, 2024Locations: 1
Eligibility criteria

1. Age ≥18 years old and ≤75 years old [+4]

1. Plasma creatinine clearance rate <30 mL/min [+14]

Read more
Status: Recruiting

ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis

The purpose of the study is to evaluate the safety and feasibility of drug coated balloon in treatment of intracranial in-stent restenosis.

Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Acotec Scientific Co., LtdUpdated: Aug 1, 2024Locations: 1
Eligibility criteria

18 to 80 years of age [+7]

Patients with stroke within 2 weeks before procedure; [+21]

Read more
Status: Recruiting

Acotec DCB Post Market Clinical Follow-up

All-comers, prospective, multi-center, single-arm, non-interventional post market clinical follow-up (PMCF) Cohort 1 - Claudicants: Rutherford Clinical Category (RCC) 2-3 Cohort 2 - Critical Limb Ischemia: Rutherford Clinical Category (RCC) 4-6

Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Acotec Scientific Co., LtdUpdated: Aug 1, 2024Locations: 7
Eligibility criteria

1. Patient is ≥ 18 years old at the time of consent. [+5]

1. Rutherford Classification Category 0, 1 [+9]

Read more
Status: Recruiting

ACOART AVF RENEW: A Post Market Clinical Study

The objective of this prospective，multi-center，single arm study is to obtain further data on the safety and performance of the Acotec Orchid＆Dhalia Drug-coated Balloon catheters for the treatment of for the obstructive lesions in the native Arteriovenous Dialysis Fistulae (AVF).

Participants needed: 164
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Acotec Scientific Co., LtdUpdated: Jan 16, 2024Locations: 1
Eligibility criteria

Patient is ≥18 and ≤85 years of age [+10]

Women who are breastfeeding, pregnant, or are intending to become pregnant, or m... [+14]

Read more